0001415889-21-002817.txt : 20210604 0001415889-21-002817.hdr.sgml : 20210604 20210604161517 ACCESSION NUMBER: 0001415889-21-002817 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210602 FILED AS OF DATE: 20210604 DATE AS OF CHANGE: 20210604 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ANDERSON DANIEL GRIFFITH CENTRAL INDEX KEY: 0001834111 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39746 FILM NUMBER: 21996624 MAIL ADDRESS: STREET 1: C/O SIGILON THERAPEUTICS, INC. STREET 2: 100 BINNEY STREET, SUITE 600 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sigilon Therapeutics, Inc. CENTRAL INDEX KEY: 0001821323 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474005543 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 BINNEY STREET STREET 2: STE 600 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-336-7540 MAIL ADDRESS: STREET 1: 100 BINNEY STREET STREET 2: STE 600 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 form4-06042021_040601.xml X0306 4 2021-06-02 0001821323 Sigilon Therapeutics, Inc. SGTX 0001834111 ANDERSON DANIEL GRIFFITH C/O SIGILON THERAPEUTICS, INC. 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 true false false false Common Stock 2021-06-02 4 S 0 200000 10 D 2022222 D /s/ Matthew Kowalsky, Attorney-in-Fact 2021-06-04